Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

NCT06371820 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06371820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 1965
Completion date
May 17, 2043
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal diseases